Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Nature Medicine
|
April 24, 2026
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial
Marie-Anne Debily, Gwenael Le Teuff, Thomas Kergrohen, et al.
The Lancet. Haematology
|
June 15, 2026
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial
Nicolò Peccatori, Franco Locatelli, Anneke C J Ammerlaan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
Steven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
Andrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
The Lancet. Oncology
|
August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
Stefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
Andrew D J Pearson, Elly Barry, Yael P Mossé, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Nature Medicine
|
April 24, 2026
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial
Marie-Anne Debily, Gwenael Le Teuff, Thomas Kergrohen, et al.
The Lancet. Haematology
|
June 15, 2026
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial
Nicolò Peccatori, Franco Locatelli, Anneke C J Ammerlaan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
Steven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
Andrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
The Lancet. Oncology
|
August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
Stefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
Andrew D J Pearson, Elly Barry, Yael P Mossé, et al.
Page
of 9